MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$33,606K
Free Cash flow
-$39,095K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from long term debt, ne...
    • Acquisition of business, net of ...
    • Proceeds from maturities of mark...
    • Others
Negative Cash Flow Breakdown
    • Proceeds from offerings, net of ...
    • Other assets and liabilities
    • Purchases of property and equipm...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net (loss) income
-17,740
-63,316
-17,666
-3,355
Depreciation and amortization expense
6,714
6,809
6,881
18,343
Stock-based compensation expense
6,342
8,996
9,780
22,382
Change in fair value of financial liabilities
-220
-2,540
-1,116
2,320
Deferred tax expense
-518
449
-
448
Provision for excess and obsolete inventory
-
-
-17
152
Legal reserves
-
-
-4,750
-810
Change in third party payor reserves
2,044
-1,022
6,297
-8,746
Loss on extinguishment of debt
0
-6,565
-
-
Impairment loss
0
31,287
0
-
Other
1,123
1,034
781
2,382
Accounts receivable
6,682
2,558
13,432
22,799
Inventory
5,662
-1,689
3,364
72
Accounts payable and accrued expenses
602
-13,168
6,915
5,185
Other assets and liabilities
10,896
9,125
-10,143
-1,827
Net cash (used in) provided by operating activities
-28,981
-32,408
-3,090
36,369
Acquisition of business, net of cash acquired and consideration on escrow paid for legacy genedx acquisition-Series Of Individually Immaterial Business Acquisitions
-
-
32,856
-
Acquisition of business, net of cash acquired and consideration on escrow paid for legacy genedx acquisition-Gene Dx
-
-
0
-
Acquisition of business, net of cash acquired
-33,195
-
-
33,195
Purchases of marketable securities
8,888
20,177
19,141
36,535
Proceeds from sales of marketable securities
1,397
875
2,062
0
Proceeds from maturities of marketable securities
11,975
8,500
10,015
33,955
Purchases of property and equipment and development of internal-use software
10,114
6,453
4,347
14,670
Proceeds from sales of assets
-
-
0
-
Development of internal-use software assets
-
-
0
-
Net cash used in investing activities
-5,630
-17,255
-11,072
-50,445
Proceeds from long term debt, net of issuance costs
96,699
-
0
-
Proceeds from offerings, net of issuance costs
-96,998
96,998
21,136
25,568
Proceeds from issuance of common stock from subscription agreements
0
476
-
-
Proceeds from issuance of common stock pursuant to employee stock purchase plan
1,793
-
1,699
1,262
Exercise of stock options
0
58
1,040
982
Repayment and principal payments for long-term debt-Perceptive Term Loan Facility
0
54,000
-
-
Long-term debt principal payments
-
-
305
906
Repayment and principal payments for long-term debt-DECDLoan Agreement
0
4,447
-
-
Finance lease principal payments
489
495
377
2,074
Net cash provided by financing activities
1,005
38,590
23,193
24,832
Net decrease in cash, cash equivalents and restricted cash
-33,606
-11,073
9,031
10,756
Cash, cash equivalents and restricted cash, at beginning of period
94,916
105,989
96,958
86,202
Cash, cash equivalents and restricted cash, at end of period
61,310
94,916
105,989
96,958
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from long termdebt, net of issuance...$96,699K Proceeds from issuance ofcommon stock pursuant...$1,793K Net cash provided byfinancing activities$1,005K Canceled cashflow$97,487K Net decrease incash, cash...-$33,606K Canceled cashflow$1,005K Depreciation andamortization expense$6,714K Stock-based compensationexpense$6,342K Other$1,123K Accounts payable andaccrued expenses$602K Acquisition of business, netof cash acquired-$33,195K Proceeds from maturitiesof marketable...$11,975K Proceeds from sales ofmarketable securities$1,397K Proceeds from offerings,net of issuance...-$96,998K Finance lease principalpayments$489K Net cash (used in)provided by operating...-$28,981K Net cash used ininvesting activities-$5,630K Canceled cashflow$14,781K Canceled cashflow$46,567K Net (loss) income-$17,740K Other assets andliabilities$10,896K Accounts receivable$6,682K something is missing-$33,195K Inventory$5,662K Change in third partypayor reserves$2,044K Deferred tax expense-$518K Change in fair value offinancial liabilities-$220K Purchases of property andequipment and development...$10,114K Purchases of marketablesecurities$8,888K

GeneDx Holdings Corp. (WGSWW)

GeneDx Holdings Corp. (WGSWW)